论文部分内容阅读
Targeted therapy is a promising way for cancer based drug development.Among variouscancer associated targets, tumor stem cells (TSCs) hold great potential as recent discoveryof their important role in cancer development and resistant to therapy.Doublecortin-likekinasel (Dclkl) is a serine-threonine kinase which has been found as a marker in tumorstem cells.